Market Overview:
The global bioresorbable surgical material market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for minimally invasive surgeries and rising prevalence of chronic diseases. Based on type, the polylactic acid (PLA) segment is expected to account for the largest share of the global bioresorbable surgical material market in 2018. PLA is a bioabsorbable polymer that has been used extensively in medical applications such as sutures, screws, and plates due to its favorable properties such as biocompatibility and degradation rate. Based on application, the drug delivery segment is expected to account for the largest share of the global bioresorbable surgical material market in 2018. This can be attributed to factors such as rising demand for targeted drug delivery systems and increasing incidence of chronic diseases worldwide.
Product Definition:
A bioresorbable surgical material is a medical device that is designed to be absorbed by the body after a certain amount of time. This type of material can be used for a variety of purposes, including tissue repair, drug delivery, and wound closure. The importance of bioresorbable surgical materials lies in their ability to dissolve away after they have served their purpose, which minimizes the risk of adverse effects and reduces the need for subsequent surgeries.
Polylactic Acid (PLA):
Polylactic Acid (PLA) is a biodegradable polymer produced from renewable resources. It has the ability to degrade in the human body as well as in the natural environment, which makes it an ideal material for use in disposable medical devices and surgical tools.
Polyglycolic Acid (PGA):
Polyglycolic acid (PGA) is a water-soluble polymer with an acidic group, which can be esterified to form hydrogels. PGA has applications in tissue engineering and drug delivery systems. It also finds application as bioresorbable surgical material for soft tissue reconstruction and as a scaffold for bone regeneration.
Application Insights:
The drug delivery application segment accounted for the largest revenue share in 2016 and is projected to continue leading over the forecast period. Bioresorbable materials are used for delivering drugs at desired locations in the body, thereby eliminating any risk of infection. Also, these materials help reduce adverse effects caused due to surgery and ensure better patient compliance.
Orthopedics was one of the fastest-growing segments owing to increasing number of knee & hip replacement surgeries across various regions. The others segment includes general surgery applications as well as cosmetic surgeries where bioresorbable polymers are used for soft tissue augmentation or reconstruction purposes only. These applications account for a very low market share as compared with other segments since these products are still considered experimental and have not been approved by regulatory authorities such as FDA or European Medicines Agency (EMA).
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing R&D investments by various companies and rising healthcare expenditure in this region. Moreover, high adoption of biodegradable materials for medical applications is also one of the major factors contributing toward regional growth.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to increasing awareness about bio-based products.
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global market for minimally invasive surgeries is expected to grow at a CAGR of 6.5% from 2016 to 2021. This is primarily owing to the benefits offered by these surgeries over traditional open surgery, such as shorter hospital stays, reduced pain and blood loss, and faster recovery times. Bioresorbable surgical materials are ideally suited for use in minimally invasive procedures as they can be easily delivered through small incisions and then dissolved or absorbed once the surgery is complete, thus eliminating the need for additional surgical procedures or follow-up visits to remove the implant.
- Growing prevalence of chronic diseases: The incidence of chronic diseases such as cancer, heart disease, and diabetes is on the rise globally due to changing lifestyles and increasing population aging rates. These conditions often require repeated interventions such as chemotherapy sessions, radiation therapy treatments, or surgery which can lead to significant scarring and other complications. Bioresorbable surgical materials can help reduce these complications by providing a scaffold that supports tissue regeneration without requiring any additional surgical procedures for removal after healing has occurred.
Scope Of The Report
Report Attributes
Report Details
Report Title
Bioresorbable Surgical Material Market Research Report
By Type
Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polysaccharides, Polycaprolactone (PCL), Others
By Application
Drug Delivery, Orthopedics, Others
By Companies
Evonik, Corbion, DSM, Mitsui Chemicals, PCAS, Poly-Med, KLS Martin
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
217
Number of Tables & Figures
152
Customization Available
Yes, the report can be customized as per your need.
Global Bioresorbable Surgical Material Market Report Segments:
The global Bioresorbable Surgical Material market is segmented on the basis of:
Types
Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polysaccharides, Polycaprolactone (PCL), Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Drug Delivery, Orthopedics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Evonik
- Corbion
- DSM
- Mitsui Chemicals
- PCAS
- Poly-Med
- KLS Martin
Highlights of The Bioresorbable Surgical Material Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Polylactic Acid (PLA)
- Polyglycolic Acid (PGA)
- Polysaccharides
- Polycaprolactone (PCL)
- Others
- By Application:
- Drug Delivery
- Orthopedics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bioresorbable Surgical Material Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bioresorbable surgical material is a type of medical device that can be dissolved or absorbed by the body after it has been used in surgery. This allows for less waste and easier disposal, as well as reduced risk of infection.
Some of the major players in the bioresorbable surgical material market are Evonik, Corbion, DSM, Mitsui Chemicals, PCAS, Poly-Med, KLS Martin.
The bioresorbable surgical material market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bioresorbable Surgical Material Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bioresorbable Surgical Material Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bioresorbable Surgical Material Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bioresorbable Surgical Material Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bioresorbable Surgical Material Market Size & Forecast, 2018-2028
4.5.1 Bioresorbable Surgical Material Market Size and Y-o-Y Growth
4.5.2 Bioresorbable Surgical Material Market Absolute $ Opportunity
Chapter 5 Global Bioresorbable Surgical Material Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Bioresorbable Surgical Material Market Size Forecast by Type
5.2.1 Polylactic Acid (PLA)
5.2.2 Polyglycolic Acid (PGA)
5.2.3 Polysaccharides
5.2.4 Polycaprolactone (PCL)
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Bioresorbable Surgical Material Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Bioresorbable Surgical Material Market Size Forecast by Applications
6.2.1 Drug Delivery
6.2.2 Orthopedics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bioresorbable Surgical Material Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bioresorbable Surgical Material Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Bioresorbable Surgical Material Analysis and Forecast
9.1 Introduction
9.2 North America Bioresorbable Surgical Material Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Bioresorbable Surgical Material Market Size Forecast by Type
9.6.1 Polylactic Acid (PLA)
9.6.2 Polyglycolic Acid (PGA)
9.6.3 Polysaccharides
9.6.4 Polycaprolactone (PCL)
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Bioresorbable Surgical Material Market Size Forecast by Applications
9.10.1 Drug Delivery
9.10.2 Orthopedics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Bioresorbable Surgical Material Analysis and Forecast
10.1 Introduction
10.2 Europe Bioresorbable Surgical Material Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Bioresorbable Surgical Material Market Size Forecast by Type
10.6.1 Polylactic Acid (PLA)
10.6.2 Polyglycolic Acid (PGA)
10.6.3 Polysaccharides
10.6.4 Polycaprolactone (PCL)
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Bioresorbable Surgical Material Market Size Forecast by Applications
10.10.1 Drug Delivery
10.10.2 Orthopedics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Bioresorbable Surgical Material Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Bioresorbable Surgical Material Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Bioresorbable Surgical Material Market Size Forecast by Type
11.6.1 Polylactic Acid (PLA)
11.6.2 Polyglycolic Acid (PGA)
11.6.3 Polysaccharides
11.6.4 Polycaprolactone (PCL)
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Bioresorbable Surgical Material Market Size Forecast by Applications
11.10.1 Drug Delivery
11.10.2 Orthopedics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Bioresorbable Surgical Material Analysis and Forecast
12.1 Introduction
12.2 Latin America Bioresorbable Surgical Material Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Bioresorbable Surgical Material Market Size Forecast by Type
12.6.1 Polylactic Acid (PLA)
12.6.2 Polyglycolic Acid (PGA)
12.6.3 Polysaccharides
12.6.4 Polycaprolactone (PCL)
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Bioresorbable Surgical Material Market Size Forecast by Applications
12.10.1 Drug Delivery
12.10.2 Orthopedics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Bioresorbable Surgical Material Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Bioresorbable Surgical Material Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Bioresorbable Surgical Material Market Size Forecast by Type
13.6.1 Polylactic Acid (PLA)
13.6.2 Polyglycolic Acid (PGA)
13.6.3 Polysaccharides
13.6.4 Polycaprolactone (PCL)
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Bioresorbable Surgical Material Market Size Forecast by Applications
13.10.1 Drug Delivery
13.10.2 Orthopedics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bioresorbable Surgical Material Market: Competitive Dashboard
14.2 Global Bioresorbable Surgical Material Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Evonik
14.3.2 Corbion
14.3.3 DSM
14.3.4 Mitsui Chemicals
14.3.5 PCAS
14.3.6 Poly-Med
14.3.7 KLS Martin
